Based on the Beximco Pharmaceuticals Limited stock forecast from 0 analysts, the average analyst target price for Beximco Pharmaceuticals Limited is not available over the next 12 months. Beximco Pharmaceuticals Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Beximco Pharmaceuticals Limited is Slightly Bearish, which is based on 2 positive signals and 3 negative signals. At the last closing, Beximco Pharmaceuticals Limited’s stock price was GBX 29.00. Beximco Pharmaceuticals Limited’s stock price has changed by -9.38% over the past week, +26.09% over the past month and -33.20% over the last year.
No recent analyst target price found for Beximco Pharmaceuticals Limited
No recent average analyst rating found for Beximco Pharmaceuticals Limited
Company Overview Beximco Pharmaceuticals Limited
N/A
N/A
N/A
N/A
GBX
UK
Adjusted Closing Price for Beximco Pharmaceuticals Limited (BXP:LSE)
Loading...
Unadjusted Closing Price for Beximco Pharmaceuticals Limited (BXP:LSE)
Loading...
Share Trading Volume for Beximco Pharmaceuticals Limited Shares
Loading...
Compare Performance of Beximco Pharmaceuticals Limited Shares
Frequently Asked Questions About Beximco Pharmaceuticals Limited (BXP:LSE) Stock
Stock Target Advisor's fundamental analysis for Beximco Pharmaceuticals Limited's stock is Slightly Bearish.
Unfortunately we do not have enough data on BXP:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BXP:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on BXP:LSE's stock to indicate if its overvalued.
The last closing price of BXP:LSE's stock was GBX 29.00.
Unfortunately we do not currently have any market capitalization data for BXP:LSE's stock.
Unfortunately we do not have enough analyst data on BXP:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Beximco Pharmaceuticals Limited's stock.
Sorry, we do not have any data on the number of employees for Beximco Pharmaceuticals Limited.
Sorry we do not have any infomation available on Beximco Pharmaceuticals Limited's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Frequently Asked Questions About Beximco Pharmaceuticals Limited (BXP:LSE) Stock
Stock Target Advisor's fundamental analysis for Beximco Pharmaceuticals Limited's stock is Slightly Bearish.
Unfortunately we do not have enough data on BXP:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BXP:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on BXP:LSE's stock to indicate if its overvalued.
The last closing price of BXP:LSE's stock was GBX 29.00.
Unfortunately we do not currently have any market capitalization data for BXP:LSE's stock.
Unfortunately we do not have enough analyst data on BXP:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Beximco Pharmaceuticals Limited's stock.
Sorry, we do not have any data on the number of employees for Beximco Pharmaceuticals Limited.
Sorry we do not have any infomation available on Beximco Pharmaceuticals Limited's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BXP:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
